Hims & Hers Health Inc (NYSE: HIMS) has seen a rise in its stock price by 2.55 in relation to its previous close of 14.51. However, the company has experienced a -4.98% decline in its stock price over the last five trading sessions. The Motley Fool reported 2024-04-06 that These stocks are reporting above-average growth rates in their respective industries and share prices are soaring. Hims & Hers Health is serving essential needs across diverse patient populations.
Is It Worth Investing in Hims & Hers Health Inc (NYSE: HIMS) Right Now?
The 36-month beta value for HIMS is also noteworthy at 0.92. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for HIMS is 138.71M, and at present, short sellers hold a 9.20% of that float. The average trading volume of HIMS on April 09, 2024 was 4.74M shares.
HIMS’s Market Performance
HIMS’s stock has seen a -4.98% decrease for the week, with a 3.69% rise in the past month and a 78.20% gain in the past quarter. The volatility ratio for the week is 5.97%, and the volatility levels for the past 30 days are at 5.52% for Hims & Hers Health Inc The simple moving average for the past 20 days is -3.08% for HIMS’s stock, with a 68.51% simple moving average for the past 200 days.
Analysts’ Opinion of HIMS
Many brokerage firms have already submitted their reports for HIMS stocks, with Imperial Capital repeating the rating for HIMS by listing it as a “Outperform.” The predicted price for HIMS in the upcoming period, according to Imperial Capital is $16 based on the research report published on February 28, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $10. The rating they have provided for HIMS stocks is “Market Perform” according to the report published on February 26th, 2024.
Imperial Capital gave a rating of “In-line” to HIMS, setting the target price at $9 in the report published on December 07th of the previous year.
HIMS Trading at 19.18% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.29% of loss for the given period.
Volatility was left at 5.52%, however, over the last 30 days, the volatility rate increased by 5.97%, as shares surge +4.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.70% upper at present.
During the last 5 trading sessions, HIMS fell by -4.98%, which changed the moving average for the period of 200-days by +76.72% in comparison to the 20-day moving average, which settled at $15.38. In addition, Hims & Hers Health Inc saw 67.19% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Baird Melissa, who sale 11,751 shares at the price of $14.74 back on Apr 08 ’24. After this action, Baird Melissa now owns 538,932 shares of Hims & Hers Health Inc, valued at $173,254 using the latest closing price.
Baird Melissa, the Chief Operating Officer of Hims & Hers Health Inc, sale 11,751 shares at $14.58 during a trade that took place back on Apr 05 ’24, which means that Baird Melissa is holding 538,932 shares at $171,372 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.82 for the gross margin
The net margin for Hims & Hers Health Inc stands at -0.03. The total capital return value is set at -0.11. Equity return is now at value -7.18, with -5.83 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 7.58. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 23.88.
Currently, EBITDA for the company is -23.95 million with net debt to EBITDA at 3.07. When we switch over and look at the enterprise to sales, we see a ratio of 3.41. The receivables turnover for the company is 152.85for trailing twelve months and the total asset turnover is 1.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.00.
Conclusion
In summary, Hims & Hers Health Inc (HIMS) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
